<DrugInformationSummary id="CDR0000767077"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>Blinatumomab works by bringing healthy T cells (immune cells that help kill cancer cells) and leukemia cells close together so the T cells can more effectively kill the leukemia cells.  It does this by binding to a protein called CD3 on healthy T cells and a protein called CD19 on B cells (the immune cells that are cancerous in acute lymphoblastic leukemia). Blinatumomab is a type of immunotherapy drug  called a bispecific T-cell engager (BiTE).</DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/blinatumomab">Blinatumomab</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000487684">blinatumomab</TerminologyLink><GlossaryLink ref="CDR0000767205">blinatumomab</GlossaryLink><USBrandNames><USBrandName>Blincyto</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>blih-nuh-TOO-moh-mab</TermPronunciation><MediaLink ref="CDR0000769372" type="audio/mpeg" alt="" language="en" id="_3"/><MediaLink ref="CDR0000769371" type="audio/mpeg" alt="" language="es" id="_4"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=38b482a8-960b-4591-9857-5031ecb830aa&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Blinatumomab</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=38b482a8-960b-4591-9857-5031ecb830aa&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_1"><Title>Use in Cancer</Title>                                                              
  <Para id="_2">Blinatumomab
         is approved 
         to treat:</Para>                          
  <ItemizedList Style="bullet" id="_5"><ListItem><Strong><GlossaryTermRef href="CDR0000543504" dictionary="Cancer.gov" audience="Patient">B-cell acute lymphoblastic leukemia</GlossaryTermRef></Strong> that is CD19 positive in adults and children aged 1 month and older. It is used:<ItemizedList Style="bullet" id="_6"><ListItem>in certain patients with cancer that is in the first or second <GlossaryTermRef href="CDR0000045651" dictionary="Cancer.gov" audience="Patient">complete remission</GlossaryTermRef></ListItem><ListItem>in patients with cancer that has come back or did not respond to treatment</ListItem><ListItem>in certain patients with cancer that does not have the <GlossaryTermRef href="CDR0000044179" dictionary="Cancer.gov" audience="Patient">Philadelphia chromosome</GlossaryTermRef> and who are in the  <GlossaryTermRef href="CDR0000045654" dictionary="Cancer.gov" audience="Patient">consolidation</GlossaryTermRef> phase of chemotherapy</ListItem></ItemizedList></ListItem></ItemizedList>
  <Para id="_4">Blinatumomab
         is also being studied in the treatment of other types of
         cancer.</Para>
 </Section><Section id="_About"><Title>More About Blinatumomab</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/487684">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para>

<Para id="_About_8.60">MedlinePlus Information on <ExternalRef xref="https://medlineplus.gov/druginfo/meds/a614061.html">Blinatumomab</ExternalRef> - A lay language summary of important information about this drug that may include the following:</Para>
<ItemizedList Style="bullet" id="_About_9.61"><ListItem>warnings about this drug,</ListItem><ListItem>what this drug is used for and how it is used,</ListItem><ListItem>what you should tell your doctor before using this drug,</ListItem><ListItem>what you should know about this drug before using it, </ListItem><ListItem>other drugs that may interact with this drug, and</ListItem><ListItem>possible side effects.  </ListItem></ItemizedList><Para id="_About_10.62">Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for.  This patient information sheet applies only to approved uses of the drug.  However, much of the information may also apply to unapproved uses that are being studied.</Para></Section><Section id="_Research"><Title>Research Results and Related Resources</Title><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2025/childhood-leukemia-blincyto-first-treatment">Blinatumomab Boosts Chemotherapy as Initial Treatment for Some Kids with ALL</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2023/blinatumomab-infant-leukemia-survival">Blinatumomab Increases Survival for Infants with an Aggressive Type of ALL</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2023/blincyto-leukemia-minimal-residual-disease">Trial Suggests Expanded Role for Blinatumomab in Treating ALL</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies">Targeted Therapy to Treat Cancer</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/monoclonal-antibodies">Monoclonal Antibodies</ExternalRef></Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C62528">Find Clinical Trials for Blinatumomab</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2014-12-22</DateFirstPublished><DateLastModified>2025-02-13</DateLastModified></DrugInformationSummary>
